intestine

Devita Devices and Intestinal Infections in Children

by with No Comment Articles

intestine

Devita Devices and Intestinal Infections in Children

This health survey was conducted under the supervision of Dr. Giatsenko Archiatroy and Dr. Fakoylinz, both paediatricians.

The investigation lasted six months in total from October 2009 to March 2010.

There was a total sample of 48 children, aged from 5 to 14 years old who were diagnosed with parasitic infestations of ascariasis and giardiasis, both common intestinal infections.

The children were divided into three groups:

  1. Treated only with prescription medication
  2. Treated only with the Deta-AP and Deta-Ritm devices
  3. Treated with prescription medications, as well as the Deta-AP and Deta-Ritm devices.

In the first group when only prescribed medication was used to eliminate these intestinal parasites, there was a 48% cure rate. In the second group where only the Deta-AP and Deta-Ritm devices were used, there was an 86% cure rate, while when both the devices and medications were combined there was a 94% cure rate.

The main disadvantages of using medications is that they have side effects that vary from patient to patient. The Deta-AP and Deta-Ritm devices however did not have any such side effects and were completey safe and easy to use with these children.

gyna

Devita AP and Gynaecological Problems

by with No Comment Articles

Devita AP and Gynaecological Problems

This survey was conducted under the supervision of Professor B.E. Sachob, beginning on 04/09/2009.

100 women were examined, aged 18 to 42 years suffering from Pelvic Inflammatory Disease (PID) associated with infections such chlamydia, mycoplasmas, ureoplasma, Cytomegalovirus, herpes and HPV – these women were divided into 3 groups:

  1. Use of Deta-AP only
  2. The use of Deta-AP along with prescription medications
  3. The use of only prescribed medications

The highest effectiveness of treatments was when the Deta-AP was combined with prescribed medications (87 – 92%) and 85% effectiveness when the Deta-AP alone was used.

When using only prescribed medications such as antibiotics and antivirals, the effectiveness dropped to 60 – 65%.

It appears that the Deta-AP can clearly compliment prescribed medications and increase their effectiveness, even though the Deta-AP used by itself can still help 85% of these PID infections.

osteoporosis

Devita Devices in the Treatment of Children

by with No Comment Articles

Devita Devices in the Treatment of Children

This survey was conducted under the supervision of the Professor of the Department of Pediatrics of the State Medical University of the Republic of Bashkortostan, Southeast Ntroyzinin.

63 children were monitored, aged 12 to 15 years (43 girls and 20 boys). All these children underwent extensive testing and clinically diagnosed.

The children were divided into two groups:

  1. Treated for calcium metabolism disorders using the drug Calcemin
  2. Treated for calcium metabolism disorders using only the Deta-Ritm and Deta-AP devices; for ten consecutive days.

Effectiveness of Treatments (%)

Health Problems Deta-Ritm & AP Devices only Drug Calcemin
Pain, appetite, indigestion 93,2% 82.6%
Inflammation, action speed 87.7% 72,1%
Statistical Testing (T-Test) 91.6% 78.3%

The results showed that the group of children treated only with the Deta-AP and Ritm devices had a statistically significant difference – more effective – than the group that was treated only with the prescription drug Calcemin.

This was for the two major health issues of digestive problems and inflammation with pain.

patient

Devita AP and RITM and Patient’s Experiences

by with No Comment Articles

Devita AP and RITM and Patient’s Experiences

This survey was conducted under the supervision of a physician and Lecturer in the Academy of Aa Panob, Russia – 33 patients were examined with varying health issues; 23 children from 2 to 17 years and 10 adults from 30 to 59 years old.

There was a variety patients with an array of different health problems, including:

  • Upper respiratory infection: 4 patients
  • Herpes: 7 patients
  • Chronic Herpes: 7 patients
  • Tinea pedis (athlete’s foot): 1 patient
  • Nasopharyngitis (caused by Candida): 2 patients
  • Ostechondrosis of the cervical and thoracic spine: part 4 patients
  • Gastro-duodenitis: 5 patients
  • Dystonia: 2 patients
  • Diabetes mellitus: type 2 – 1 patients

The overall conclusion reached was that the combined treatments using the Deta-Ritm and Deta-AP devices had improved the overall health of 75% of the patient population after only 2-3 days of using the devices. The overall general effectiveness of all the treatments was 97%.

Patients generally tolerated the treatments without complaining about being inconvenienced as the treatments were mostly conducted in the patient’s home.

There were no side effects reported from any of these patients.